Camden Capital, LLC Cara Therapeutics, Inc. Transaction History
Camden Capital, LLC
- $896 Million
- Q3 2024
A detailed history of Camden Capital, LLC transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Camden Capital, LLC holds 12,682 shares of CARA stock, worth $3,931. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,682Holding current value
$3,931% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CARA
# of Institutions
74Shares Held
12.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA2.25MShares$697,1620.0% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$527,6540.06% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$482,4370.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.11MShares$345,0430.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.11MShares$343,7680.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $16.7M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...